Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic effect of ondansetron in parturients undergoing cesarean section
PACTR202011750758363Phase 4Not yet recruiting
- Sponsor
- Dilla University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ondansetron (2 arms), sponsored by Dilla University. Primary endpoints: Hypotension and Bradycardia. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
ondansetron
Beyond the preview
Go deeper on PACTR202011750758363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202011750758363.